Vicarious Surgical (NYSE: RBOT) leaders accept voluntary salary cuts

Rhea-AI Filing Summary

Vicarious Surgical Inc. reported changes to executive compensation for two senior leaders. On March 4, 2026, the company entered into amendments to the Executive Employment Agreements for Adam Sachs, its President, and Sammy Khalifa, its Chief Technology Officer.

Under these amendments, Mr. Sachs agreed to voluntarily reduce his annual base salary to approximately $270,810, and Mr. Khalifa agreed to reduce his annual base salary to approximately $318,600. Despite these reductions, any target bonus amounts and severance payments under their employment agreements will continue to be calculated using the higher base salaries that were in effect immediately before these amendments. The amendments are filed as Exhibits 10.1 and 10.2.

false 0001812173 0001812173 2026-03-04 2026-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 4, 2026

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39384		87-2678169
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

78 Fourth Avenue
Waltham, Massachusetts		02451
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 868-1700

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common stock, par value $0.0001 per share		RBOT		The New York Stock Exchange*

* On March 3, 2026, the New York Stock Exchange determined to commence proceedings to delist and immediately suspend trading in the Class A common stock, par value $0.0001 per share, of Vicarious Surgical Inc. The registrant’s Class A common stock is currently quoted on the OTCID market tier operated by The OTC Markets Group, Inc. under the symbol “RBOT.”

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Employment Agreement Amendments

On March 4, 2026, Vicarious Surgical Inc. (the “Company”) entered into amendments (the “Employment Agreement Amendments”) to the Executive Employment Agreements (the “Employment Agreements”) between the Company and each of Adams Sachs, the President of the Company, and Sammy Khalifa, the Chief Technology Officer of the Company.

Pursuant to their respective Employment Agreement Amendments, Mr. Sachs and Mr. Khalifa agreed to voluntarily reduce their annual base salaries to approximately $270,810 and $318,600, respectively. Notwithstanding the salary reductions, however, any target bonus amounts or severance payment amounts payable pursuant to the Employment Agreements will continue to be calculated on the basis of the base salaries as in effect for Mr. Sachs and Mr. Khalifa immediately prior to the execution of the Employment Agreement Amendments.

The foregoing descriptions of the Employment Agreement Amendments are summaries and do not purport to be complete. Such descriptions are qualified in their entirety by reference to the text of the Employment Agreement Amendments for Mr. Sachs and Mr. Khalifa, which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
10.1		Amendment to Executive Employment Agreement, dated as of March 4, 2026, between Vicarious Surgical Inc. and Adam Sachs
10.2		Amendment to Executive Employment Agreement, dated as of March 4, 2026, between Vicarious Surgical Inc. and Sammy Khalifa
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICARIOUS SURGICAL INC.
	By:	/s/ Stephen From
	Name:	Stephen From
	Title:	Chief Executive Officer

Date: March 6, 2026

2

FAQ

What executive pay changes did Vicarious Surgical (RBOT) disclose in this 8-K?

Vicarious Surgical disclosed voluntary base salary reductions for two executives. President Adam Sachs reduced his annual base salary to about $270,810, and Chief Technology Officer Sammy Khalifa reduced his to about $318,600, effective through amendments signed on March 4, 2026.

Which Vicarious Surgical (RBOT) executives are affected by the March 4, 2026 amendments?

The amendments affect Adam Sachs, President of Vicarious Surgical, and Sammy Khalifa, the company’s Chief Technology Officer. Each entered into an Employment Agreement Amendment on March 4, 2026, changing the level of their annual base salaries while leaving other key compensation calculations unchanged.

How do the salary cuts impact bonuses and severance at Vicarious Surgical (RBOT)?

The salary cuts do not change how bonuses and severance are calculated. Target bonus amounts and severance payments for Adam Sachs and Sammy Khalifa will continue to be based on the higher base salaries that applied immediately before the March 4, 2026 Employment Agreement Amendments.

When were the Vicarious Surgical (RBOT) executive employment amendments signed?

The Employment Agreement Amendments for Vicarious Surgical’s President Adam Sachs and Chief Technology Officer Sammy Khalifa were signed on March 4, 2026. That date is specified as the effective date of the amendments attached as Exhibits 10.1 and 10.2 to the current report.

Where can investors find the full text of Vicarious Surgical (RBOT) executive amendments?

Investors can review the full text of the amendments in Exhibits 10.1 and 10.2. These exhibits are the Amendment to Executive Employment Agreement for Adam Sachs and for Sammy Khalifa, each dated March 4, 2026, and incorporated by reference in the current report.

Filing Exhibits & Attachments

5 documents

Agreements & Contracts

• EX-10.1 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF MARCH 4, 2026, BETWEEN 9.4 KB
• EX-10.2 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF MARCH 4, 2026, BETWEEN 9.6 KB

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.9 KB